Inverse agonist activity of agouti and agouti-related protein

被引:73
作者
Chai, BX
Neubig, RR
Millhauser, GL
Thompson, DA
Jackson, PJ
Barsh, GS
Dickinson, CJ
Li, JY
Lai, YM
Gantz, I
机构
[1] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Ctr Med, Dept Pediat, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Ctr Med, Dept Pharmacol & Internal Med, Ann Arbor, MI 48109 USA
[4] Univ Calif Santa Cruz, Dept Chem, Santa Cruz, CA 95064 USA
[5] Univ Calif Santa Cruz, Dept Biochem, Santa Cruz, CA 95064 USA
[6] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA
[7] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA
[8] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA
关键词
melanocortin; obesity; hypothalamus; pigmentation; JKC-363; JKC-366;
D O I
10.1016/S0196-9781(03)00104-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Agouti and agouti-related protein (AgRP) are endogenous antagonists of the melanocortin receptors (MCxR). Previous data showed that recombinant full-length agouti and a synthetic fragment of AgRP, AgRP (83-132), are inverse agonists at the MC1R and MC4R, respectively. This study demonstrates the smaller analogs AgRP (87-120) and ASIP [90-132 (L89Y)], and short peptides Yc[CRFFNAFC]Y and Qc[CRFFRSAC]S are also MC4R inverse agonists. Furthermore, the relative affinity of the series of MC4R ligands for displacement of radiolabeled antagonist I-125-AgRP (86-132) versus radiolabeled agonist I-125-NDP-MSH did not correlate with ligand efficacy, which is more consistent with an induced-fit model than a simple two-state model of MC4R activation. These data shed new light on the determinants and mechanism of inverse agonism at the MC4R. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:603 / 609
页数:7
相关论文
共 29 条
  • [1] ACTH- and α-MSH-induced grooming, stretching, yawning and penile erection in male rats:: Site of action in the brain and role of melanocortin receptors
    Argiolas, A
    Melis, MR
    Murgia, S
    Schlöth, HB
    [J]. BRAIN RESEARCH BULLETIN, 2000, 51 (05) : 425 - 431
  • [2] BAROVSKY K, 1985, MOL PHARMACOL, V28, P502
  • [3] AGOUTI ANTAGONISM OF MELANOCORTIN BINDING AND ACTION IN THE B16F10 MURINE MELANOMA CELL-LINE
    BLANCHARD, SG
    HARRIS, CO
    ITTOOP, ORR
    NICHOLS, JS
    PARKS, DJ
    TRUESDALE, AT
    WILKISON, WO
    [J]. BIOCHEMISTRY, 1995, 34 (33) : 10406 - 10411
  • [4] BOURNE HR, 1992, BASIC CLIN PHARM, P10
  • [5] Inverse agonist activity of pirenzepine at M2 muscarinic acetylcholine receptors
    Daeffler, L
    Schmidlin, F
    Gies, JP
    Landry, Y
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (05) : 1246 - 1252
  • [6] CALCULATING RECEPTOR NUMBER FROM BINDING EXPERIMENTS USING SAME COMPOUND AS RADIOLIGAND AND COMPETITOR
    DEBLASI, A
    OREILLY, K
    MOTULSKY, HJ
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (06) : 227 - 229
  • [7] Agouti and agouti-related protein: Analogies and contrasts
    Dinulescu, DM
    Cone, RD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (10) : 6695 - 6698
  • [8] ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors
    Fong, TM
    Mao, C
    MacNeil, T
    Kalyani, R
    Smith, T
    Weinberg, D
    Tota, MR
    VanderPloeg, LHT
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 237 (03) : 629 - 631
  • [9] The mouse mahogany locus encodes a transmembrane form of human attractin
    Gunn, TM
    Miller, KA
    He, L
    Hyman, RV
    Davis, RW
    Azarani, A
    Schlossman, SF
    Duke-Cohan, JS
    Barsh, GS
    [J]. NATURE, 1999, 398 (6723) : 152 - 156
  • [10] Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor
    Haskell-Luevano, C
    Monck, EK
    [J]. REGULATORY PEPTIDES, 2001, 99 (01) : 1 - 7